SUMO modifications play an important role in controlling the function of several proteins including transcription factors ( ). SUMO 20 proteins are conjugated to proteins through a series of enzymatic steps including conjugation to the E2-conjugating enzyme Ubc9 (see for review ( )). Targeted lysine residues are part of the consensus site KxD/E, where is a hydrophobic amino acid, K is the modified 21
lysine, x represents any residue and D or E is an acidic residue. However, SUMO conjugation needs a fourth class of proteins, the in vivo so-called E3-ligating enzymes, such as the Protein Inhibitor of Activated STAT (PIAS) family, which are implicated in the specificity of the substrate recognition by the SUMO pathway. Finally, SENP desumoylase family catalyzes the de-conjugation of SUMO from their substrate.
In this report, we show that hPPAR is conjugated with SUMO-1 , in Cos-7 cells and in the human hepatoma cell line HuH-7.
α in vitro
In addition, hPPAR directly interacts with the E2-conjugating enzyme Ubc9. Furthermore, we demonstrate that the E3-ligating α in vitro enzyme PIASy regulates hPPAR SUMO-1 conjugation. The SUMOylation site of human PPAR was mapped to the lysine residue at α α position 185, located in the hinge region of the receptor. Arginine substitution of this lysine residue increased the transcriptional activity of hPPAR suggesting that SUMOylation of this lysine reduces hPPAR trans-activity, which is explained by a facilitated recruitment of the α α corepressor NCoR, but not SMRT, upon hPPAR SUMOylation. We also demonstrate that the SUMO pathway specifically decreases α NCoR-specific hPPAR target gene expression. Finally, we demonstrate that the hPPAR ligand GW7647 reduces hPPAR α α α
SUMOylation.
EXPERIMENTAL PROCEDURES Materials
DMEM and fetal calf serum (FCS), glutamine and gentamycine were purchased from Invitrogen Life Technologies (Cergy Pontoise, France). The human hepatoma HuH-7 cell line and Cos-7 cell lines were purchased from LGC Promochem (Molsheim, France). GW7647
was kindly provided by Glaxo-SmithKline (Les Ulis, France). JetPEI was purchased from Ozyme (Saint-Quentin en Yvelines, France).
Redivue L-( S)-Methionine was purchased from Amersham Pharmacia Biotech (Saclay, France). The pSG5-hPPAR and J6-TK-Luc 35 α were described previously ( ). The pSG5-hRXR , pCI-SMRT, pKCR2-NCoR full-length expression vectors were kindly provided by Dr. 
Site-directed mutagenesis
The pSG5-hPPAR K R, K R, K R, K R, K R, K R expression vectors were generated using pSG5-hPPAR WT as 
Transient transfection experiments
HuH-7 cells, cultured in 24-well plates (5 10 cells per well), were transfected with 10 ng of J6-TK-Luc, 100 ng of pSV-
-galactosidase, 5 ng of pSG5-hPPAR (WT or K R) expression vectors and indicated amounts of pKCR2-NCoR, pCI-SMRT, activity was analysed with Mithras LB 940 luminometer (Berthold Technologies, Thoiry, France). As transfection control, -galactosidase β activity was analysed as previously described. by RT Q-PCR ( ). figure 1A and 1B
SiRNA transient transfection

GST Pull-Down assay
GST pull-down assays have been performed as previously described ( ). Briefly, BL21-Star pGEX4T2-Ubc9 and BL21-star 
Nickel pull down assay
Transfected cells were lysed in denaturating conditions using 6M-guanidine hydrochloride. His-SUMO-conjugated proteins were recovered with Ni -nitrilotriacetic acid (Ni-NTA) beads (Qiagen, Courtaboeuf, France) as previously described ( ). Recovered proteins 2 +
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were then separated by SDS-PAGE and analysed by western blotting.
In vitro SUMOylation assays
modification was carried out with purified recombinant products provided by SUMOlink kit (Active Motif, Rixensart, In vitro SUMO Belgium) and S-methionine-labeled PPAR proteins generated by transcription/translation in reticulocyte extract (Promega, autoradiography.
Coimmunoprecipitation
HuH-7 cells were cross-linked with 1.5 mM Ethylene glycol-bis(SuccinimidylSuccinate) (Thermo Fisher Scientific, Rockford, USA)
for 20 minutes at room temperature. After ice-cold PBS washes, cells were lysed with lysis buffer (Tris-HCl 20 mM, pH 7.5; NaCl 150 mM; EDTA 1 mM; EGTA 1 mM; Triton X-100 1 ; protease inhibitors). 300 g of recovered proteins were incubated with FLAG M2 % μ monoclonal antibodies agarose (Sigma, St Louis, USA) overnight at 4 C. Beads were washed four times with ice-cold TBS and eluted°w ith Laemmli buffer. Protein amounts were analysed by western blotting.
RESULTS
Human PPAR target genes are regulated in a NCoR-or SMRT-specific manner α As previously described, LXR target genes can be regulated in a NCoR-and/or SMRT-specific manner ( ). However, such 16 mechanism has not been described so far for hPPAR . To investigate this hypothesis, HuH-7 cells were transfected either with siRNA for SMRT ( , respectively). Inversely, expression is increased in absence of SMRT but not in absence of figure 1C and 1D HMGCOAS2 NCoR ( ). These data suggest that and are NCoR-sensitive hPPAR target genes, whereas is a figure 1E L-CPT1 PDK4 α HMGCOAS2 SMRT-regulated hPPAR target gene. was specifically analysed by western blotting using anti-PPAR antibodies. As shown in , SUMOylation of hPPAR strongly α α figure 2E α decreased in presence of GW7647 compared to vehicle. These data suggest that ligand binding either impairs the SUMOylation of hPPAR or promotes its desumoylation. To investigate whether GW7647 has an effect on the cellular SUMOylation pattern, HuH-7 cells were α transfected with a SUMO-1 expression vector in presence of GW7647 and Histidine-tagged SUMOylated proteins were analysed by western blotting using anti-His antibodies. As shown in , GW7647 does not modify the amount of other SUMOylated proteins, 6 figure 2F
suggesting that PPAR ligand GW7647 does not modulate the SUMOylation machinery in a general manner. suggesting that SUMO pathway inhibits their expression ( ). Interestingly, gene expression, which was not figure 4A C -HMGCOAS2 altered by NCoR silencing ( ), was not affected by Ubc9 silencing. To evaluate the role of hPPAR on the observed effect of figure 1E α Ubc9 knockdown, we analysed the expression of these genes in cells cotransfected with both siRNA for PPAR and Ubc9. Our results α show that the impact of siRNA Ubc9 on and expression is abolished in presence of siRNA PPAR , suggesting that the L-CPT1 PDK4 figure 1 pathway selectively inhibits NCoR-specific hPPAR target genes in a hPPAR -dependent manner. mutagenesis by an unSUMOylatable arginine, a residue with a similar steric hindrance. Each hPPAR mutant protein was analysed for α their ability to be SUMOylated . As shown in , no band corresponding to SUMOylated protein was visible with the in vitro figure 5A mutant hPPAR K R, indicating that hPPAR is modified by SUMO-1 in its hinge region on lysine 185. latter encodes the VP16-AD protein fused to the C-terminal domain of NCoR, which includes the nuclear receptor interacting domain)
Increasing amounts of VP16-NCoR stimulated hPPAR WT transcription activity more pronouncedly than hPPAR K R, indicating that
the NCoR protein interacts with hPPAR WT with a higher efficiency than hPPAR K R.
We also assessed the role of SUMOylation in the functional interaction between hPPAR and NCoR by co-transfecting HuH-7 cells show that, in contrast to PPAR WT, the SUMOylation-defective hPPAR K R form did not interact with the NCoR protein, figure 7C α α 185 confirming our previous results ( ). As control, we performed a similar experiment with HuH-7 cells transfected with the figure 7A pEF-FLAG empty vector and NCoR expression vector. As expected, NCoR proteins were not precipitated in this condition (data not shown).
Similarly, the impact of hPPAR SUMOylation was assessed on the interaction between the corepressor SMRT and hPPAR ( α α figure 8 ). For that purpose, HuH-7 cells were transfected with the J6-TK-Luc reporter vector, the hPPAR WT or hPPAR K R, and increasing α α 185 amounts of VP16-AD or VP16-SMRT vectors. By contrast to NCoR ( ), increasing amounts of SMRT similarly activated WT and figure 7 K R hPPAR proteins, indicating that the K R mutation in hPPAR has no effect on the interaction of hPPAR with the corepressor In accordance with the one-hybrid results, the transcriptional activity of both hPPAR WT and hPPAR K R was decreased to a similar α α 185 extent by SMRT. Altogether, these data show that the hPPAR K R protein is still sensitive to repression by SMRT but not to NCoR.
α 185
DISCUSSION
In this report, we show that hPPAR target gene expression can be down-regulated by NCoR ( ) or by SMRT (
) in a gene-specific manner. It has been previously shown that NCoR can be recruited by SUMO-modified nuclear receptors HMGCOAS2 ( , ). Our study reports that hPPAR binds to the E2-conjugating enzyme Ubc9 providing evidence that PPAR is able to interact 24 25 α α directly with SUMO pathway components. Therefore, we investigated whether hPPAR is SUMOylated and whether this SUMOylation In addition, the regulation of SUMO conjugation to a substrate protein upon phosphorylation of the target protein has already been reported for several nuclear receptors such as GR and PPAR ( , ). We have previously shown that Protein Kinase C can γ 32 33 phosphorylate hPPAR on serines 179 and 230, which are very close to the lysine 185. The serine 230 is not conserved between mice and α human and could be involved in the species-specific SUMOylation of the hPPAR protein. with siRNA NCoR and siRNA Ubc9, PIASy-overexpression has no effect on the expression of , which is a gene specifically HMGCOAS2 regulated by SMRT ( ). Using the mutant protein hPPAR K R we showed that SUMOylation of hPPAR promotes NCoR figure 1 7 16 However, mice treated with this ligand show increased SUMOylated PPAR , suggesting that the ligand could act on PPAR α α SUMOylation in a cell type-selective manner.
In conclusion, this study provides the first evidence of SUMOylation of hPPAR on lysine 185 resulting in the downregulation of its α transcriptional activity by promoting its interaction with the corepressor NCoR. This is consistent with the ability of the ligand to inhibit hPPAR SUMOylation preventing the binding of NCoR to the nuclear receptor, which leads to its activation. Moreover, this study α demonstrates that the SUMO pathway regulates the recruitment of the corepressor NCoR but not SMRT. This differential recruitment leads to a differential inhibition of specific hPPAR target genes. Finally, our work provides further evidence of the relevance of the α hPPAR hinge region in the regulation of corepressor recruitment.
α
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Figure 4
Effect of SUMO pathway modulation on PPAR target genes in HuH-7 cells α HuH-7 cells were transfected with siRNA Ubc9 and/or siRNA hPPAR . Then RNA was extracted and the expression of ( ), 
Figure 5
SUMOylation of hPPAR occurs on lysine 185 α translated S -methionine hPPAR WT, hPPAR K R, hPPAR K R, hPPAR K R, hPPAR K R, hPPAR K R, A. In vitro blotting using anti-PPAR antibodies. The SUMO1-His input proteins were analysed by western blotting using anti-His antibodies.
Figure 6
The transcriptional activity of hPPAR K R is increased compared to hPPAR WT 
Figure 7
The hPPAR K R mutant displays a lower physical and functional interaction with NCoR compared with hPPAR WT -galactosidase activities were measured in transfected cell lysates and the ratio luciferase activity/ -galactosidase activity was determined. . HuH-7 cells were transfected with the J6-TK-Luc, with pSV--galactosidase, with the pSG5 control vector, or the pSG5-hPPAR WT or A β α pSG5-hPPAR K R expression vectors, and with increasing amounts of VP16-AD or VP16-SMRT vectors. The luciferase and α 185 β -galactosidase activities were measured in transfected cell lysates and the ratio luciferase activity/ -galactosidase activity was determined. pCI-SMRT expression vector. The luciferase and -galactosidase activities were measured in transfected cell lysates and the ratio luciferase β activity/ -galactosidase activity was determined. Then, pCI-SMRT curves were compared to their respective pCI control curves. Results are β expressed as relative inhibition. Each bar is the mean value SD of triplicate determinations. pCI curves are not represented.
±
Figure 9
Comparison of the SUMOylation consensus site in mouse, rat and human PPARα PPAR primary protein sequences in mouse, rat and human were compared by using BLASTP algorithm. represents identical amino acids α * and : represents different amino acids.
